Description
PATHOLOGY
First action · last action
2015-10-01 · 2015-10-01
Transactions
1
First transaction's obligation
$109,260
Base + all options value (sum of deltas)
$109,260
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-01+$109,260= $109,260
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-01 | +$109,260 | $109,260 | PATHOLOGY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI E7WGWEK19Y79)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26326N0005 | NETWORK CONTRACT OFFICE 23 (36C263) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $165,318 | FY2026 |
| 36C26325D0022 | NETWORK CONTRACT OFFICE 23 (36C263) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2025 |
| 36C26325N0347 | NETWORK CONTRACT OFFICE 23 (36C263) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $93,827 | FY2025 |
| 36C26325N0181 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $1,150 | FY2025 |
| 36C24125N0019 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $119,990 | FY2025 |
| 36C26324N0050 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $74,349 | FY2024 |
Other recipients under 6505 from 549-DALLAS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25716P0113 | MCKESSON CORPORATION | 549-DALLAS | $11,630 | FY2016 |
| VA25715J2597 | GRIFOLS BIOLOGICALS LLC | 549-DALLAS | $129,005 | FY2015 |
| VA25715C0028 | BARD PERIPHERAL VASCULAR, INC. | 549-DALLAS | $11,400 | FY2015 |
| VA25714J3693 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 549-DALLAS | $7,512 | FY2014 |
| VA25714J3691 | ACTELION PHARMACEUTICALS US, INC. | 549-DALLAS | $5,435 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25716P0178_3600_-NONE-_-NONE- · retrieved 2026-09-26.